Nobabelle (Ethinylestradiol, Gestodene)

Ethinylestradiol and Gestodene, the active ingredients in Nobabelle, are a combined oral contraceptive presented as an oral tablet for oral use. It provides hormonal contraception for women of reproductive age to prevent unintended pregnancy.

GNH USA supplies Nobabelle as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nobabelle is a combined oral contraceptive used within the family‑planning and reproductive‑health pathway. - Contraception: prevents pregnancy in women of childbearing age. - Family planning: enables control over reproductive timing. - Hormonal birth control: provides reliable, reversible fertility management.

Nobabelle may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Breast tenderness: discomfort or swelling of the breasts. - Headache: occasional throbbing pain. - Spotting: irregular vaginal bleeding. - Mood changes: irritability or emotional fluctuations. - Weight gain: slight increase in body weight.

Serious or Rare Side Effects: - Deep vein thrombosis: blood clot formation in deep veins. - Pulmonary embolism: clot migration to lung vessels. - Stroke: interruption of cerebral blood flow. - Myocardial infarction: heart attack risk. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Liver dysfunction: jaundice or abnormal liver enzymes.

Before prescribing Nobabelle, clinicians should assess individual risk factors and counsel patients on safe use. - Pregnancy contraindication: avoid use during pregnancy. - Smoking restriction: do not smoke >15 cigarettes per day while using. - Cardiovascular assessment: evaluate history of thromboembolic events. - Liver disease caution: use with caution in hepatic impairment. - Drug interaction review: check for concomitant enzyme‑inducing agents. - Store at ambient temperature: keep below 25 °C, in original packaging, protected from moisture.

Nobabelle can interact with several medicines that affect its efficacy or safety.

Major Interactions (Avoid): - Rifampicin, carbamazepine, phenytoin: potent enzyme inducers that reduce contraceptive effectiveness. - Griseofulvin: induces hepatic enzymes, lowering hormone levels. - HIV protease inhibitors (e.g., ritonavir): may increase hormone concentrations, raising clot risk.

Moderate Interactions (Monitor Closely): - Ketoconazole, itraconazole: antifungals that can increase hormone levels. - Selective serotonin reuptake inhibitors (SSRIs): may modestly affect metabolism. - Antihypertensives (e.g., ACE inhibitors): monitor blood pressure changes.